Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension

Pathologies of the micro-and macrovascular systems are a hallmark of the metabolic syndrome, which can lead to chronically elevated blood pressure. However, the underlying pathomechanisms involved still need to be clarified. Here, we report that an obesity-associated increase in serum leptin triggers the select expansion of the micro-angioarchitecture in pre-autonomic brain centers that regulate hemodynamic homeostasis. By using a series of cell-and region-specific loss-and gain-of-function models, we show that this pathophysiological process depends on hypothalamic astroglial hypoxia-inducible factor 1a-vascular endothelial growth factor (HIF1a-VEGF) signaling downstream of leptin signaling. Importantly, several distinct models of HIF1a-VEGF pathway disruption in astrocytes are protected not only from obesity-induced hypothalamic angiopathy but also from sympathetic hyperactivity or arterial hypertension. These results suggest that hyperleptinemia promotes obesity-induced hypertension via a HIF1a-VEGF signaling cascade in hypothalamic astrocytes while establishing a novel mechanistic link that connects hypothalamic micro-angioarchitecture with control over systemic blood pressure.

Automated summary

This study found that hyperleptinemia promotes obesity-induced hypertension through a HIF1a-VEGF signaling cascade in hypothalamic astrocytes. Blocking the HIF1a-VEGF pathway in astrocytes can protect from obesity-induced hypothalamic angiopathy, sympathetic hyperactivity, or arterial hypertension.